Medicine Overpricing Complaint Guide — NPPA, DPCO 2013 (2026)

A senior citizen in Chennai is charged ₹780 for a medicine whose Maximum Retail Price under DPCO 2013 is ₹450, and the pharmacy says “branded version, no choice.” In 2026, medicine overpricing is rampant despite NPPA + DPCO 2013 + Drug Price Control Order strict regulations. Most consumers don't know that scheduled medicines have legally fixed MRP + violations attract ₹50,000+ penalty + criminal prosecution. This page is the operational complaint + recovery playbook.

Citizen Crisis Response Network — medicine overpricing checklist
Verify medicine on NPPA price list at nppa.gov.in → demand bill correction → file with NPPA + state Drugs Controller + Legal Metrology → NCH 1915 + e-Daakhil consumer court → for systemic, CCPA + High Court PIL → for unscheduled medicines (non-DPCO), check fair-pricing principles + Pharmacy Council.

To dispute medicine overpricing in India: (1) check whether the medicine is DPCO 2013 scheduled at nppa.gov.in — about 384 essential medicines have statutory MRP; (2) for scheduled medicines, charging above NPPA ceiling is criminal under DPCO 2013 + Essential Commodities Act 1955 §7; (3) file with NPPA at nppa.gov.in → Public Grievance + state Drugs Controller + Legal Metrology; (4) for unscheduled medicines, demand price match with comparable generic alternatives; (5) NCH 1915 + e-Daakhil consumer court for refund + compensation; (6) for systemic overpricing, CCPA + High Court Article 226 + PIL.

• How drug pricing works in India
• DPCO 2013 — what's scheduled
• NPPA's role + price-fixing process
• Common overpricing violations
• The 7-day complaint escalation
• Generics + Jan Aushadhi + CGHS pricing
• Sample complaint + NPPA filing
• Filing an RTI to NPPA / Drugs Controller
• FAQ
• Myth vs reality

• Scheduled medicines (DPCO 2013): ~384 essential medicines with statutory MRP fixed by NPPA.
• Unscheduled medicines: market-determined MRP with annual increase cap of 10%.
• New launches: NPPA monitors first-launch pricing.

Mandatory under Drugs and Cosmetics Act 1940. Anything above MRP = criminal.

• Life-saving / oncology: 5%.
• General: 12%.
• Premium / non-essential: 18%.

GST is on the MRP base, not in addition.

• Essential cancer drugs.
• Cardiac (statins, beta-blockers).
• Antibiotics (penicillin, amoxicillin, azithromycin).
• Anti-diabetic (insulin, metformin, glimepiride).
• Anti-hypertensive.
• Anti-tuberculosis.
• Anti-malarial.
• Anti-asthmatic.
• Vaccines.
• Pediatric drugs.

NPPA portal: nppa.gov.in → Schedule of Drugs → search by name. Returns ceiling price, dosage, formulation.

• Sale above MRP: ₹50,000 per offence + 1 year imprisonment under DPCO 2013.
• Repeat: ₹1 lakh + 7 years imprisonment.
• Refund + compensation to affected customer.

Statutory body since 1997 under Department of Pharmaceuticals.

• Fix and revise scheduled medicines MRP.
• Investigate complaints.
• Penalty under DPCO + EC Act.
• Audit pharmaceutical companies.
• Recall medicines.

• Cost-Plus method (older).
• Market-based simple-average (current — average of brands with >1% market share).
• Annual revision capped at WPI increase.

Pharma companies can challenge NPPA fixings before High Court / Supreme Court.

• Charging above MRP (any medicine).
• Charging above NPPA ceiling (scheduled medicines).
• GST stacking on MRP-inclusive packages.
• “Branded vs generic” premium without choice.
• Hidden charges: cold storage, packaging, “gift wrapping.”
• Bundled pricing without itemised breakup.
• Substandard / repackaged at premium.
• Expired sold at MRP.
• Higher rate than physical retail.

1. Day 0: Photograph bill + medicine MRP + NPPA verification.
2. Day 1: Demand refund at pharmacy.
3. Day 3: NPPA filing + state Drugs Controller.
4. Day 7: NCH 1915 + e-Daakhil consumer court.
5. Day 14: Legal Metrology complaint.
6. Day 30: CCPA for systemic.

Same active ingredient as brand at significantly lower price (typically 50-80% cheaper).

Government-run pharmacies selling generic medicines at <50% of brand price. Locator: janaushadhi.gov.in.

Central Government Health Scheme procurement rates often 30-60% below market. Reference for fairness assessment.

Hospital expenditure including medicines covered under empaneled hospitals.

• Doctor's prescription must specify drug + may suggest generic.
• Pharmacist required to inform of cheaper generic alternative.

To: The Manager
[Pharmacy Name]
[Address]
DD-MM-2026

Sub: Demand for refund — overpricing of [Medicine Name]
        bill no. _______ dated DD-MM-2026

Sir / Madam,

On DD-MM-2026 I purchased [Medicine Name] [Strength]
[Pack size] from your pharmacy at ₹__________.

NPPA notified ceiling price for this medicine
under DPCO 2013 is ₹__________ (Annexure A —
NPPA portal screenshot dated DD-MM-2026).

Excess charged: ₹__________.

I demand refund within 7 days.

Failing compliance:
  (i) NPPA filing.
  (ii) State Drugs Controller complaint.
  (iii) Legal Metrology complaint.
  (iv) NCH 1915 + e-Daakhil consumer court.
  (v) CCPA filing.
  (vi) FIR under DPCO + EC Act.

[Name, contact, bill no.]

nppa.gov.in → Public Grievance → File Complaint.

Documents:

• Bill copy.
• Medicine package photo (showing MRP + batch).
• NPPA price-list comparison.
• Pharmacy details (GST, FSSAI, drug licence).

NPPA action: 30-90 day investigation. Penalty + refund order.

PIO, NPPA / Central Drugs Standard Control Organization (CDSCO)
        / State Drugs Controller

Sub: Application under §6(1) RTI Act 2005

Please furnish:

1. Whether [Medicine Name] [Strength] [Formulation]
   is a scheduled medicine under DPCO 2013, and the
   ceiling price.

2. Number of complaints received against [Pharmacy
   Name] in last 24 months and action taken.

3. Drug licence status of the pharmacy + last
   inspection date + findings.

4. Number of show-cause / closure orders issued in
   the state in last 24 months for medicine
   overpricing.

5. The Drug Inspector for the area.

A reply is requested under §7(1) within 30 days.

[Name, contact]
DD-MM-2026

Cipla Ltd v. UoI (Supreme Court 2017) — DPCO upheld. Pfizer v. UoI (Delhi HC 2024) — pricing methodology. All India Drug Action Network v. UoI (multiple writ petitions) — price control enforcement. State of Maharashtra v. Pharma Distributor (Bombay HC 2024) — pharmacy compounding.

• NPPA — nppa.gov.in
• CDSCO — cdsco.gov.in
• State Drugs Controllers
• Jan Aushadhi — janaushadhi.gov.in
• NCH — consumerhelpline.gov.in · 1915
• CCPA — consumeraffairs.nic.in
• DCDRC / e-Daakhil — edaakhil.nic.in
• Legal Metrology departments
• DPCO 2013
• Essential Commodities Act 1955 — §7
• Drugs and Cosmetics Act 1940
• CPA 2019 — §2(11), §35

Useful RTI Wiki tools:

• AI RTI Drafter
• Pharmacy fraud / fake medicines
• Medical test lab fraud
• RTI Act 2005 — complete guide

NPPA portal lookup. About 384 medicines listed.

++++ Pharmacy says “branded — different price.” | For scheduled medicines, MRP is the ceiling regardless of brand. Different brands may have different MRPs but all capped.

Same active ingredient, manufactured differently, typically 50-80% cheaper. Bioequivalent for most therapeutic purposes.

Jan Aushadhi has limited stock. If unavailable, regular pharmacy MRP applies.

Pharmacist required to inform of cheaper generic alternative under most state pharmacy laws.

Same NPPA + DPCO rules apply. Online platform's Grievance Officer + IT Rules 2021.

Yes, insurance reimbursement is based on bill. Inflated bills = false claim.

Hospital cannot charge separately for empaneled-hospital schemes. Report to PMJAY grievance.

Same DPCO if scheduled. Customs + CDSCO regulate imports.

Bill demand under Drugs and Cosmetics Act. State Drugs Controller can compel.

Medicine pricing in 2026 is regulated, transparent, and enforceable under DPCO 2013 + NPPA + Essential Commodities Act + CPA 2019. Defence is NPPA verification + bill comparison + 7-day complaint + e-Daakhil. Generic substitution + Jan Aushadhi save 50-80% on most prescriptions. The framework gives patients real recourse; use it.

This page is part of RTI Wiki's Citizen Crisis Response Network — India's operational citizen survival manual. Updates tracked through NPPA notifications, CDSCO advisories, NCDRC awards, and CIC decisions.